Literature DB >> 27872260

Familial Aggregation and Heritability of Schizophrenia and Co-aggregation of Psychiatric Illnesses in Affected Families.

I-Jun Chou1,2, Chang-Fu Kuo3,4, Yu-Shu Huang5,6, Matthew J Grainge7, Ana M Valdes3, Lai-Chu See4,8, Kuang-Hui Yu4,6, Shue-Fen Luo4,6, Lu-Shuang Huang4, Wen-Yi Tseng9,10, Weiya Zhang3, Michael Doherty3.   

Abstract

Strong familial aggregation of schizophrenia has been reported but there is uncertainty concerning the degree of genetic contribution to the phenotypic variance of the disease. This study aimed to examine the familial aggregation and heritability of schizophrenia, and the relative risks (RRs) of other psychiatric diseases, in relatives of people with schizophrenia using the Taiwan National Health Insurance Database. The study population included individuals with affected first-degree or second-degree relatives identified from all beneficiaries (n = 23 422 955) registered in 2013. Diagnoses of schizophrenia made by psychiatrists were ascertained between January 1, 1996 and December 31, 2013. Having an affected co-twin, first-degree relative, second-degree relative, or spouse was associated with an adjusted RR (95% CI) of 37.86 (30.55-46.92), 6.30 (6.09-6.53), 2.44 (1.91-3.12), and 1.88 (1.64-2.15), respectively. Compared with the general population, individuals with one affected first-degree relative had a RR (95% CI) of 6.00 (5.79-6.22) and those with 2 or more had a RR (95% CI) of 14.66 (13.00-16.53) for schizophrenia. The accountability for the phenotypic variance of schizophrenia was 47.3% for genetic factors, 15.5% for shared environmental factors, and 37.2% for non-shared environmental factors. The RR (95% CI) in individuals with a first-degree relative with schizophrenia was 3.49 (3.34-3.64) for mood disorders and 3.91 (3.35-4.57) for delusional disorders. A family history of schizophrenia is therefore associated with a higher risk of developing schizophrenia, mood disorders, and delusional disorders. Heritability and environmental factors each account for half of the phenotypic variance of schizophrenia.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Entities:  

Keywords:  delusional disorders; familial aggregation; heritability; mood disorders; schizophrenia

Mesh:

Year:  2017        PMID: 27872260      PMCID: PMC5581894          DOI: 10.1093/schbul/sbw159

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


Introduction

Schizophrenia is a chronic mental disorder presenting with positive (delusions, and hallucinations, incoherent speech, and disorganized thinking) and/or negative (restricted affect, empty speech content, decreased motivation, and social withdrawal) symptoms.[1] Although schizophrenia is a mental disease with relatively low prevalence it is a leading cause of global attributable disease burden.[2] The median point estimate of global schizophrenia prevalence is approximately 0.5% according to a recent systematic review summarizing estimates drawn from 46 countries.[3] In Taiwan, the prevalence of schizophrenia in 2001 was estimated to be 0.64% using nationwide data,[4] and the direct and indirect economic costs of the condition are substantial.[5] Ample evidence suggests that schizophrenia is subject to strong familial predisposition, implying that both genetic and shared environmental factors contribute significantly to the phenotypic variance of the disorder. A population-based study using the Danish registry reports several environmental factors, such as urban birth and immigration status, which contribute significantly to schizophrenia susceptibility.[6] Heritability, the degree of genetic contribution to phenotypic variance, has been estimated to range between 41% and 87%.[7-13] In general, heritability estimates derived from twin studies are higher than those based on the general population. One estimate for heritability based on a meta-analysis of 12 twin studies was 81%.[12] However, an estimate calculated from the population-based data of the Swedish Multi-generation Register was lower, though still substantial, at 64%.[13] The heritability of schizophrenia is high, but only part of it can be explained by known associated alleles, suggesting the existence of “missing heritability.” A genetic risk profile score based on 108 genetic loci reported by a large genome-wide association (GWA) study explained only 7% of the variation on the liability scale.[14] Another GWA study, which enrolled 3322 European individuals with schizophrenia and 3587 controls, reported that the variance explained by markers that tag the causal alleles ranged from 32% to 36%.[15] Furthermore, common genetic variants underlying schizophrenia and bipolar disorder have been reported using the Swedish database.[13] Rasic et al[16] reported a 1.62-fold risk of mood disorders among offspring of parents with schizophrenia in a recent meta-analysis. Offspring of parents with severe mental illness (SMI) are at increased risk for a range of psychiatric disorders and one-third of them may develop a SMI by early adulthood. Evidence for the familial co-aggregation of schizophrenia and other psychiatric illnesses has been reported rarely in other populations. The notion of schizophrenia as a highly heritable disease is supported by current literature, but parameters that are important for genetic counseling, such as the absolute and relative risk (RR) of the disease, heritability, and the proportion of sporadic cases, are lacking for the Asian population. The sizable “missing heritability” implies either undiscovered genetic associations or overestimated heritability. The familial co-aggregation between schizophrenia and other mental disorders also needs verification. In previous years, we have developed a nationwide genealogy, and linked this to health information derived from Taiwan’s National Health Insurance (NHI) Research Database. Using the comprehensive health information and pedigree data of the entire population, this study aims to estimate the RRs of schizophrenia in individuals who have affected relatives of specific kinship, and to examine the relative contribution of genetic, shared and non-shared environmental factors to schizophrenia susceptibility. In addition, we estimated the RRs of other psychiatric illnesses associated with a family history of schizophrenia.

Methods

Study Population

This study received ethical approval from the Institutional Review Board of the Chang Gung Memorial Hospital (104-8209B). Our primary data source is the Taiwan NHI database, which contains registration and original claims data of all residents in Taiwan. The program achieved in 2013 the exceptionally high coverage rate of 99.5%.[17] Since 1995, the NHI Database records gender, date of birth, place of residence, details of insurance, family relationships, dates of inpatient and outpatient visits, medical diagnoses, medical expenditures, prescription details, vaccination status, examinations, operations, procedures, and fees incurred. We used the registry of beneficiaries, a part of the NHI database, to construct a cohort comprising all NHI beneficiaries registered in 2013. Among them, we identified all patients with schizophrenia, mood disorders and delusional disorders from the registry of catastrophic illness patients, these diagnoses being ascertained up to December 31, 2013. Individuals with a positive family history of schizophrenia in 2013 were identified and classified according to the particular kinship of affected relatives. Individuals without valid insurance status were excluded from analysis. Methods for genealogy reconstruction using recorded family relationships in the NHI database are reported in our previously published manuscripts.[18-20] In brief, we rely upon the recorded relationships between the insured persons and their dependents to identify family relationships. We established family relationships (parents, offspring, full siblings, twins, and spouse) using the identifiers and unique personal identification of parents, grandparents, children, grandchildren, and spouse. In addition to the direct ascertainment of relationships using information recorded in the registry, indirect identification of parent-offspring relationships was achieved using an algorithm.[18-20] Full siblings of an individual are ascertained if they had the same parents. Twins are ascertained as full siblings with the same date of birth (±1 d), but twin zygosity cannot be derived from the database. Among 29 505 197 individuals contained in the registry of beneficiaries, 7 856 663 do not have dependents or act as dependents, and therefore we could not identify their relatives. The rest of the beneficiaries were classified into 4 042 209 families. The mean family size was 5.4 persons. There were 2 to 5 generations in these families. Each individual may appear multiple times in different categories of family relationships depending on family structure.

Ascertainment of Schizophrenia, Mood Disorders, and Delusional Disorders

In Taiwan, patients with suspected mental illnesses are referred to psychiatrists for diagnosis and treatment. Patients diagnosed with schizophrenia, mood disorders, and delusional disorders are entitled to a waiver for medical co-payment. Clinical information relevant to the diagnosis is sent to the NHI Administration for review by expert panels to confirm the diagnosis before approval of waivers. In Taiwan, schizophrenia, mood disorders, and delusional disorders are diagnosed by psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), which is also used to assist the review of certificate applications for these mental disorders.[21] The Registry for Catastrophic Illness Patients contains all information of patients with schizophrenia (International Classification of Disease, 9th Revision [ICD-9] code, 295 except 295.8), mood disorders (ICD-9 code, 296), and delusional disorders (ICD-9 code, 297). We used this registry to identify patients with these diagnoses.

Statistical Analysis

We calculated RRs of schizophrenia, mood disorders and delusional disorders as the adjusted prevalence ratios between the first- or second-degree relatives of an individual with schizophrenia and the general population,[22] using the Breslow-Cox proportional hazards model[23,24] with a robust sandwich method to handle intra-familial clustering.[25] The RR was adjusted for age, gender, occupation categories, income level quintiles, level of urbanization of residence, and family size.[13,26] We also conducted age- and sex-adjusted models, the results of which were similar to the full model. We present these results in the supplementary tables 1–3. We fitted models separately according to the kinship and sex of affected relatives. Twins were excluded from the sibling analyses. We also compared the risk of schizophrenia in individuals with 1 or 2 affected first-degree relatives with the risk in the general population. Heritability is the proportion of phenotypic variance attributable to genetic factors, and the familial transmission is the proportion of both genetic and shared environmental contribution, both of which are calculated using the liability threshold model.[27-29] With information on background disease prevalence and kinship-specific RR for the disease, this model partitions the phenotypic variance into genetic and environmental components for dichotomous traits such as disease diagnosis.[19,30] We used the equation developed by Yang et al[30] to estimate both the familial transmission and heritability. We used the spouse as a control to separate genetic and non-shared environmental contributions to phenotypic variance, assuming that spouses share no genetics with other blood relatives but share the family environment. Therefore, assortative mating was not considered in our model. We restricted family history to first-degree relatives and assumed an average of 2 siblings per family (details of statistical analysis are shown in the supplementary material). All statistical hypotheses were tested on the 2-sided 5% level of significance. All analyses were performed using SAS v. 9.3 (SAS institute).

Results

Schizophrenia Prevalence in Individuals With Affected First-degree Family Members vs the General Population

The study population comprised 23 422 955 individuals enrolled in NHI in Taiwan in 2013. Among these 47.45%, 57.45%, 47.29%, and 1.51% had a parent, child, sibling, or twin identified, respectively. We identified 101 189 patients with the diagnosis of schizophrenia, giving a crude prevalence of 0.43%. Men had a slightly higher prevalence (0.46%) than women (0.40%), with a male:female ratio of 1.15:1. Other baseline characteristics are shown in table 1. In 2013, in the general population of Taiwan 160 587 (0.7%) individuals had at least 1 first-degree relative with schizophrenia, specifically: 64 154 with an affected parent; 50 660 with affected offspring; 47 570 with an affected sibling; and 328 with an affected twin. The age-specific prevalence of schizophrenia was statistically significantly higher in individuals with affected first- and second-degree relatives with schizophrenia than in the general population (figure 1).
Table 1.

Baseline Characteristics of Individuals With First-Degree Relatives Diagnosed With Schizophrenia and the General Population

WomenMen
VariableWith Affected FDRGeneral Population P-valueWith Affected FDRGeneral Population P-value
No.81 38711 903 54280 35711 519 413
Age, mean (SD), y41.9 (19.5)39.5 (20.9)<.000141.2 (19.7)38.6 (21.0)<.0001
Schizophrenia, No. (%)2539 (3.12)47 867 (0.40)2465 (3.07)53 322 (0.46)
Place of residence, No. (%)
 Urban24 519 (30.13)3 694 254 (31.04)<.000122 124 (27.53)3 298 256 (28.63)<.0001
 Suburban24 106 (29.62)3 434 164 (28.85)23 073 (28.71)3 269 766 (28.38)
 Rural32 762 (40.25)4 775 054 (40.11)35 160 (43.75)4 951 325 (42.98)
Income levels, No. (%)
 Quintile 124 184 (29.71)2 526 384 (21.22)<.000123 676 (29.46)2 426 365 (21.06)<.0001
 Quintile 28800 (10.81)1 318 491 (11.08)7671 (9.55)1 174 855 (10.20)
 Quintile 321 106 (25.93)3 360 952 (28.23)21 959 (27.33)3 303 888 (28.68)
 Quintile 414 449 (17.75)2 289 602 (19.23)13 167 (16.39)2 104 521 (18.27)
 Quintile 512 793 (15.72)2 398 414 (20.15)13 836 (17.22)2 502 208 (21.72)
Occupation, No. (%)
 Dependents of the insured individuals27 449 (33.73)4 471 275 (37.56)<.000120 115 (25.03)3 704 412 (32.16)<.0001
 Civil servants, teachers, military personnel, and veterans3944 (4.85)442 845 (3.72)4743 (5.90)570 766 (4.95)
 Nonmanual workers and professionals23 343 (28.68)3 398 109 (28.55)27 082 (33.7)3 708 631 (32.19)
 Manual workers17 837 (21.92)2 631 992 (22.11)16 994 (21.15)2 304 125 (20.00)
 Other8814 (10.83)959 321 (8.06)11 423 (14.22)1 231 479 (10.69)

Note: FDR, first-degree relative.

Fig. 1.

Age-specific prevalence of schizophrenia in individuals with a first-degree (circle), or second-degree (square) relative with schizophrenia and in the general population (triangle) in Taiwan in 2013.

Baseline Characteristics of Individuals With First-Degree Relatives Diagnosed With Schizophrenia and the General Population Note: FDR, first-degree relative. Age-specific prevalence of schizophrenia in individuals with a first-degree (circle), or second-degree (square) relative with schizophrenia and in the general population (triangle) in Taiwan in 2013.

RRs for Schizophrenia in Individuals With Affected First-Degree Relatives

Prevalence (recurrence risk) of schizophrenia in individuals with affected first- and second-degree relatives of specific types are shown in tables 2 and 3, respectively. The RRs (95% CIs) for schizophrenia were associated with the degree of genetic distance between family relatives. Overall, having an affected co-twin (50% or 100% genetic similarity depending on zygosity), an affected first-degree relative (on average 50% genetic similarity), an affected second-degree relative (on average 25% genetic similarity) or an affected spouse (no genetic similarity) was associated with an adjusted RR (95% CI) of 37.86 (30.55–46.92), 6.30 (6.09–6.53), 2.44 (1.91–3.12), or 1.88 (1.64–2.15), respectively. In addition, RRs increased with the number of types of affected first-degree relative. Compared with the general population, individuals with one type of affected first-degree relative had a RR (95% CI) of 6.00 (5.79–6.22), and those with 2 or more had a RR (95% CI) of 14.66 (13.00–16.53) for schizophrenia. The sex of the affected relative contributed minimally to the RR of schizophrenia. For example, the RR (95% CI) for individuals with an affected female first-degree relative was 6.86 (6.58–7.16), compared to 6.15 (5.88–6.44) for those with an affected male first-degree relative. The sex of the affected relative contributed to a similar extent to RR for schizophrenia in the case of second-degree relatives (table 3). The RRs (95% CIs) were: 8.58 (8.15–9.04) for those with affected siblings; 7.26 (6.94–7.6) for those with affected parents; 4.06 (3.85–4.27) for those with affected offspring; 2.54 (1.79–3.60) for those with an affected aunt or uncle; 2.03 (1.44–2.88) for those with an affected niece or nephew; 2.72 (1.88–3.94) for those with an affected grandparent; and 2.87 (1.60–5.16) for those with affected grandchildren.
Table 2.

Relative Risks (RRs) of Schizophrenia in Individuals With First-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status

Type of Affected RelativeSex of Affected RelativeSex of IndividualNo. of CasesPrevalence (%)RRs (95% CIs)a
AnyMaleMale12853.206.01 (5.62–6.42)
Female12632.576.10 (5.78–6.42)
All25583.066.15 (5.88–6.44)
FemaleMale12983.165.71 (5.42–6.01)
Female14383.627.98 (7.48–8.51)
All27363.396.86 (6.58–7.16)
AllMale24653.075.73 (5.49–5.98)
Female25393.126.72 (6.43–7.02)
All50043.096.30 (6.09–6.53)
ParentMaleMale2682.096.39 (5.69–7.17)
Female1471.256.23 (5.32–7.30)
All4151.696.50 (5.91–7.15)
FemaleMale7533.526.41 (6.01–6.84)
Female5422.898.99 (8.30–9.74)
All12953.237.58 (7.20–7.99)
AllMale10062.966.38 (6.02–6.75)
Female6842.258.21 (7.65–8.82)
All16902.637.26 (6.94–7.60)
OffspringMaleMale1841.352.57 (2.23–2.97)
Female6273.514.99 (4.63–5.38)
All8112.584.09 (3.83–4.37)
FemaleMale1151.262.35 (1.96–2.81)
Female4524.045.53 (5.06–6.04)
All5672.794.31 (3.98–4.67)
AllMale2891.292.44 (2.18–2.73)
Female10253.575.03 (4.75–5.33)
All13142.574.06 (3.85–4.27)
SiblingMaleMale8185.808.04 (7.41–8.73)
Female5003.698.55 (7.87–9.29)
All13184.778.50 (8.00–9.03)
FemaleMale4874.447.47 (6.86–8.14)
Female4394.4011.16 (9.94–12.53)
All9264.429.14 (8.51–9.82)
AllMale12635.097.69 (7.24–8.18)
Female8983.869.36 (8.72–10.05)
All21614.498.58 (8.15–9.04)
TwinMaleMale5436.7324.6 (17.31–34.95)
Female25.4112.21 (4.34–34.32)
All5630.4328.85 (21.56–38.61)
FemaleMale14.179.08 (1.29–64.05)
Female5545.4565.93 (51.14–85.01)
All5638.6254.98 (41.92–72.11)
AllMale5532.1623.85 (16.95–33.56)
Female5736.0856.67 (44.17–72.69)
All11234.0437.86 (30.55–46.92)
SpouseFemaleMale1751.291.45 (1.25–1.68)
MaleFemale1922.052.74 (2.38–3.15)
AllAll3671.601.88 (1.64–2.15)

Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.

Table 3.

Relative Risks (RRs) of Schizophrenia in Individuals With Second-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status

Type of Affected RelativeSex of Affected RelativeSex of IndividualNo. of CasesPrevalence (%)RRs (95% CIs)a
AnyMaleMale200.181.64 (0.94–2.88)
Female300.272.57 (1.77–3.74)
All500.232.16 (1.55–3.01)
FemaleMale310.232.84 (2.00–4.04)
Female260.202.55 (1.53–4.24)
All570.212.74 (2.03–3.70)
AllMale500.202.19 (1.61–2.98)
Female560.242.58 (1.90–3.52)
All1050.222.44 (1.91–3.12)
Aunt/uncleMaleMale80.131.50 (0.75–2.98)
Female140.242.89 (1.61–5.17)
All220.192.18 (1.35–3.53)
FemaleMale80.253.35 (1.69–6.65)
Female70.233.14 (1.52–6.50)
All150.243.30 (2.01–5.42)
AllMale160.172.08 (1.28–3.37)
Female210.242.98 (1.89–4.71)
All370.212.54 (1.79–3.60)
Niece/nephewMaleMale80.801.49 (0.75–2.94)
Female71.252.20 (1.07–4.54)
All150.961.76 (1.07–2.88)
FemaleMale101.312.57 (1.42–4.66)
Female61.542.65 (1.21–5.77)
All161.392.53 (1.58–4.05)
AllMale170.981.86 (1.17–2.95)
Female131.372.39 (1.40–4.06)
All301.122.03 (1.44–2.88)
GrandparentMaleMale30.082.86 (0.94–8.66)
Female40.113.29 (1.24–8.74)
All70.103.05 (1.46–6.35)
FemaleMale120.132.73 (1.52–4.91)
Female100.112.52 (1.37–4.67)
All220.122.63 (1.71–4.03)
AllMale150.112.76 (1.64–4.63)
Female140.112.71 (1.61–4.56)
All290.112.72 (1.88–3.94)
GrandchildrenMaleMale10.282.35 (0.33–16.71)
Female50.502.04 (0.85–4.88)
All60.442.63 (1.19–5.82)
FemaleMale30.083.92 (0.55–27.94)
Female40.112.25 (0.86–5.93)
All70.103.15 (1.32–7.53)
AllMale40.102.95 (0.74–11.79)
Female90.202.16 (1.13–4.12)
All110.132.87 (1.60–5.16)

Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.

Relative Risks (RRs) of Schizophrenia in Individuals With First-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size. Relative Risks (RRs) of Schizophrenia in Individuals With Second-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.

Familial Resemblance and Heritability of Schizophrenia

Using a liability threshold model, we estimated the accountability for phenotypic variance of schizophrenia to be 47.3% for genetic factors (heritability), 15.5% for shared environmental factors, and 37.2% for non-shared environmental factors. Given the parameters estimated previously, the probability of a patient with schizophrenia having sporadic disease was 83.3%.

Co-aggregation of Mood Disorders and Delusional Disorders

Table 4 presents adjusted RRs (95% CIs) of other psychiatric illnesses in individuals with affected first- and second-degree relatives compared to the general population. The RR (95% CI) in individuals with an affected first-degree relative with schizophrenia was 3.49 (3.34–3.64) for mood disorders and 3.91 (3.35–4.57) for delusional disorders. For those with an affected second-degree relative the RR (95% CI) was 1.55 (1.23–1.96) for mood disorders and 3.71 (2.06–6.67) for delusional disorders.
Table 4.

Relative Risks (RRs) of Mood and Delusional Disorders in Individuals With First-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status

Psychiatric IllnessesSexWith Affected RelativesGeneral PopulationRRs (95% CIs)a
No. of CasesPrevalence (%)No. of CasesPrevalence (%)
With first-degree relatives diagnosed with schizophrenia
 Mood disordersMale8351.0429 6930.243.52 (3.29–3.77)
Female12641.5548 9050.413.43 (3.25–3.62)
All20991.3078 5980.333.49 (3.34–3.64)
 Delusional disordersMale610.0823280.023.42 (2.67–4.38)
Female930.1127520.024.31 (3.52–5.26)
All1540.1050800.023.91 (3.35–4.57)
With second-degree relatives diagnosed with schizophrenia
 Mood disordersMale320.1329 6930.241.73 (1.21–2.46)
Female390.0848 9050.411.42 (1.04–1.93)
All710.1578 5980.331.55 (1.23–1.96)
 Delusional disordersMale60.0323280.024.33 (1.82–10.31)
Female50.0227520.022.99 (1.35–6.62)
All110.0250800.023.71 (2.06–6.67)

Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.

Relative Risks (RRs) of Mood and Delusional Disorders in Individuals With First-Degree Relatives Diagnosed With Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.

Discussion

Principle Findings

The prevalence of schizophrenia in individuals with an affected first-degree relative is 6.3-fold higher, and with an affected second-degree relative 2.4-fold higher than in the general population, indicating a dose-response relationship between the risk of schizophrenia and genetic distance. This finding is in line with previous twin studies reporting a high concordance of schizophrenia. Familial factors contribute approximately two-thirds of phenotypic variance while genetic factors contribute approximately half of total variance. The magnitude of familial aggregation and heritability is substantial but is lower than estimates reported by previous studies.[12,13] We further report a higher prevalence of mood disorders and delusional disorders in people with a family history of schizophrenia. Despite this familial risk, similar to many other common complex diseases,[19,30] most cases of schizophrenia are expected to be sporadic.

Comparison With Previous Estimates of Heritability

Heritability reported in this study is in the lower range of previously reported estimates. However, measurements of schizophrenia heritability may be subject to variation in study design, source population, studied kinships, and case definitions of schizophrenia. Twin studies have generally reported high heritability, ranging between 41% and 87%.[7-12] A study by Lichtenstein et al[13] that involved a sample of the Swedish population found a slightly lower heritability of 64.3%, while our estimate derived from the entire population of Taiwan was even lower at 47.3%. However, our estimate of familial transmission of 62.8% is very similar to that reported in the Swedish study (68.8%).[13] The difference in heritability estimates may in part be due to differences in the methods used to partition familial transmission into heritability and shared environmental factors. We used the spouse as a control, while Lichtenstein analyzed outcomes from nuclear, paternal half-sibling, and maternal half-sibling families. Our methods could have underestimated heritability due to the effect of assortative mating, which nullifies the assumption of zero genetic correlation between spouses.[31] However, assortative mating has been found to be of minor relevance in family studies,[32] although ideally this needs confirmation in our population. In addition, the fact that the heritability estimate cannot be higher than that of familial transmission suggests that only if shared environmental factors were nonexistent would the heritability of schizophrenia approach previous estimates, while environmental factors such as birth place and season seem to account for more population impact on the risk of schizophrenia.[10] Therefore the environmental contribution to schizophrenia susceptibility seem to be greater than previously thought. Currently schizophrenia is subject to much missing heritability since only a fraction of heritability can be explained by GWA studies.[33] Factors such as a heritable epigenetic component or structural variation,[34] gene–gene interactions among loci,[35] and contributions from rare variants[36] may partly explain missing heritability, and in general it is hard to ascertain these factors in GWA studies. Another possibility is that the heritability of schizophrenia is lower than that estimated previously in twin studies and therefore the extent of missing heritability might be overestimated.

Familial Co-aggregation of Schizophrenia and Other Mental Disorders

A family history of schizophrenia is also a risk factor for mood and delusional disorders. Although several smaller studies have found no association between a family history of schizophrenia and mood disorders,[37-39] more recent studies generally support the theory that families with schizophrenia patients are enriched with cases of unipolar[40] or bipolar disorder.[41] A recent meta-analysis found an increased risk for a range of psychiatric disorders, including schizophrenia and mood disorders, among offspring of parents with SMI.[16] A nationwide study from Sweden found that having a parent or sibling with schizophrenia was associated respectively with a 5.2- and 3.7-fold increased risk of bipolar disorder. In addition to epidemiological evidence, data from the International Schizophrenia Consortium (ISC) case-control sample, which genotyped 3322 European individuals with schizophrenia and 3587 controls, found substantial shared genetic liability between schizophrenia and bipolar disorder.[15] Furthermore, the genetic correlation is estimated to be 0.68 between schizophrenia and bipolar disorder, and 0.43 between schizophrenia and major depression.[42] Previous evidence for familial co-aggregation between schizophrenia and delusional disorders is insufficient and conflicting.[43-45] Our data support the co-aggregation of schizophrenia with both mood disorders and delusional disorders. This suggests that these other psychiatric illnesses share part of the pathogenesis of schizophrenia.

Limitations

There are several limitations to the present study. Firstly, the case definitions are based purely on the diagnosis recorded in the Registry for Catastrophic Illness Patients. Detailed information on patients’ clinical findings is not available in the database, therefore we cannot validate the diagnoses. Nevertheless, our case definitions are based on a psychiatrist-made diagnosis that is corroborated by an expert panel so we consider these case definitions to be stringent. Secondly, the zygosity of twins is not recorded in the database so we cannot estimate heritability using a classic twin study design. Thirdly, because we estimated heritability using the liability threshold model the results are subject to the assumption that diseases result from underlying liability that is normally distributed in the population. Although this is a potential caveat, a previous study of other mental diseases supports the validity of this model and the application of this model to mental diseases.[46] Additionally, recent GWA studies strongly support the polygenic basis of schizophrenia.[15,47] Fourthly, we could not account for the effects of assortative mating. If these effects are not negligible, heritability could have been underestimated. Patients with schizophrenia also tend to have fewer offspring, and we adjusted the family size to account for this effect. Fifthly, this study was restricted to Taiwan, and it is possible that different results would be obtained in different populations and environments. Therefore, further studies in other countries are required to determine the generalizability of this study’s findings. Furthermore, we reconstructed nationwide genealogy based on the family relationships that are recorded in the NHI in order to grant eligibility of dependent status, therefore the complete ascertainment of family relationships was not possible since some people do not need family relationships to maintain NHI eligibility. For example, migrants, foreigners living in Taiwan for more than 6 months, people relying on government subsidies, and Taiwanese citizens living overseas are also eligible for NHI. Nevertheless, it was possible to ascertain familial relationships in the majority of permanent residents in Taiwan. Also ascertainment of cases with psychiatric illnesses and family relationships are unrelated processes, so any differential ascertainment of schizophrenia cases is expected to be minimal. Lastly, residual confounding may exist. We adjusted for residence, income, occupation, and family size,[26] which may contribute to the risk of schizophrenia.[26] However, other factors, such as level of education, have been implicated as risk factors but these are not available in the NHI database so cannot be considered.

Conclusions

This nationwide family study confirms that in Taiwan a positive family history of schizophrenia is one of the strongest risk factors for schizophrenia and other psychiatric illnesses. Differential risk associated with different kinships suggests a strong genetic component in susceptibility to schizophrenia. These findings may be useful in counseling the families of schizophrenia patients.

Supplementary Material

Supplementary material is available at http://schizophreniabulletin.oxfordjournals.org. Click here for additional data file.
  46 in total

1.  The mystery of missing heritability: Genetic interactions create phantom heritability.

Authors:  Or Zuk; Eliana Hechter; Shamil R Sunyaev; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-05       Impact factor: 11.205

2.  Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996-2001.

Authors:  I-Chia Chien; Yiing-Jenq Chou; Ching-Heng Lin; Shin-Huey Bih; Pesus Chou; Hong-Jen Chang
Journal:  Psychiatry Clin Neurosci       Date:  2004-12       Impact factor: 5.188

3.  The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus.

Authors:  D S Falconer
Journal:  Ann Hum Genet       Date:  1967-08       Impact factor: 1.670

4.  A twin study of genetic relationships between psychotic symptoms.

Authors:  Alastair G Cardno; Frühling V Rijsdijk; Pak C Sham; Robin M Murray; Peter McGuffin
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

5.  The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives.

Authors:  K S Kendler; M McGuire; A M Gruenberg; A O'Hare; M Spellman; D Walsh
Journal:  Arch Gen Psychiatry       Date:  1993-07

6.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

Authors:  A E Farmer; P McGuffin; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1987-07

7.  Family structure and risk factors for schizophrenia: case-sibling study.

Authors:  Jari K Haukka; Jaana Suvisaari; Jouko Lönnqvist
Journal:  BMC Psychiatry       Date:  2004-11-27       Impact factor: 3.630

8.  Familial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Ana M Valdes; Lai-Chu See; Shue-Fen Luo; Kuang-Hui Yu; Weiya Zhang; Michael Doherty
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

9.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.

Authors:  S Hong Lee; Stephan Ripke; Benjamin M Neale; Stephen V Faraone; Shaun M Purcell; Roy H Perlis; Bryan J Mowry; Anita Thapar; Michael E Goddard; John S Witte; Devin Absher; Ingrid Agartz; Huda Akil; Farooq Amin; Ole A Andreassen; Adebayo Anjorin; Richard Anney; Verneri Anttila; Dan E Arking; Philip Asherson; Maria H Azevedo; Lena Backlund; Judith A Badner; Anthony J Bailey; Tobias Banaschewski; Jack D Barchas; Michael R Barnes; Thomas B Barrett; Nicholas Bass; Agatino Battaglia; Michael Bauer; Mònica Bayés; Frank Bellivier; Sarah E Bergen; Wade Berrettini; Catalina Betancur; Thomas Bettecken; Joseph Biederman; Elisabeth B Binder; Donald W Black; Douglas H R Blackwood; Cinnamon S Bloss; Michael Boehnke; Dorret I Boomsma; Gerome Breen; René Breuer; Richard Bruggeman; Paul Cormican; Nancy G Buccola; Jan K Buitelaar; William E Bunney; Joseph D Buxbaum; William F Byerley; Enda M Byrne; Sian Caesar; Wiepke Cahn; Rita M Cantor; Miguel Casas; Aravinda Chakravarti; Kimberly Chambert; Khalid Choudhury; Sven Cichon; C Robert Cloninger; David A Collier; Edwin H Cook; Hilary Coon; Bru Cormand; Aiden Corvin; William H Coryell; David W Craig; Ian W Craig; Jennifer Crosbie; Michael L Cuccaro; David Curtis; Darina Czamara; Susmita Datta; Geraldine Dawson; Richard Day; Eco J De Geus; Franziska Degenhardt; Srdjan Djurovic; Gary J Donohoe; Alysa E Doyle; Jubao Duan; Frank Dudbridge; Eftichia Duketis; Richard P Ebstein; Howard J Edenberg; Josephine Elia; Sean Ennis; Bruno Etain; Ayman Fanous; Anne E Farmer; I Nicol Ferrier; Matthew Flickinger; Eric Fombonne; Tatiana Foroud; Josef Frank; Barbara Franke; Christine Fraser; Robert Freedman; Nelson B Freimer; Christine M Freitag; Marion Friedl; Louise Frisén; Louise Gallagher; Pablo V Gejman; Lyudmila Georgieva; Elliot S Gershon; Daniel H Geschwind; Ina Giegling; Michael Gill; Scott D Gordon; Katherine Gordon-Smith; Elaine K Green; Tiffany A Greenwood; Dorothy E Grice; Magdalena Gross; Detelina Grozeva; Weihua Guan; Hugh Gurling; Lieuwe De Haan; Jonathan L Haines; Hakon Hakonarson; Joachim Hallmayer; Steven P Hamilton; Marian L Hamshere; Thomas F Hansen; Annette M Hartmann; Martin Hautzinger; Andrew C Heath; Anjali K Henders; Stefan Herms; Ian B Hickie; Maria Hipolito; Susanne Hoefels; Peter A Holmans; Florian Holsboer; Witte J Hoogendijk; Jouke-Jan Hottenga; Christina M Hultman; Vanessa Hus; Andrés Ingason; Marcus Ising; Stéphane Jamain; Edward G Jones; Ian Jones; Lisa Jones; Jung-Ying Tzeng; Anna K Kähler; René S Kahn; Radhika Kandaswamy; Matthew C Keller; James L Kennedy; Elaine Kenny; Lindsey Kent; Yunjung Kim; George K Kirov; Sabine M Klauck; Lambertus Klei; James A Knowles; Martin A Kohli; Daniel L Koller; Bettina Konte; Ania Korszun; Lydia Krabbendam; Robert Krasucki; Jonna Kuntsi; Phoenix Kwan; Mikael Landén; Niklas Långström; Mark Lathrop; Jacob Lawrence; William B Lawson; Marion Leboyer; David H Ledbetter; Phil H Lee; Todd Lencz; Klaus-Peter Lesch; Douglas F Levinson; Cathryn M Lewis; Jun Li; Paul Lichtenstein; Jeffrey A Lieberman; Dan-Yu Lin; Don H Linszen; Chunyu Liu; Falk W Lohoff; Sandra K Loo; Catherine Lord; Jennifer K Lowe; Susanne Lucae; Donald J MacIntyre; Pamela A F Madden; Elena Maestrini; Patrik K E Magnusson; Pamela B Mahon; Wolfgang Maier; Anil K Malhotra; Shrikant M Mane; Christa L Martin; Nicholas G Martin; Manuel Mattheisen; Keith Matthews; Morten Mattingsdal; Steven A McCarroll; Kevin A McGhee; James J McGough; Patrick J McGrath; Peter McGuffin; Melvin G McInnis; Andrew McIntosh; Rebecca McKinney; Alan W McLean; Francis J McMahon; William M McMahon; Andrew McQuillin; Helena Medeiros; Sarah E Medland; Sandra Meier; Ingrid Melle; Fan Meng; Jobst Meyer; Christel M Middeldorp; Lefkos Middleton; Vihra Milanova; Ana Miranda; Anthony P Monaco; Grant W Montgomery; Jennifer L Moran; Daniel Moreno-De-Luca; Gunnar Morken; Derek W Morris; Eric M Morrow; Valentina Moskvina; Pierandrea Muglia; Thomas W Mühleisen; Walter J Muir; Bertram Müller-Myhsok; Michael Murtha; Richard M Myers; Inez Myin-Germeys; Michael C Neale; Stan F Nelson; Caroline M Nievergelt; Ivan Nikolov; Vishwajit Nimgaonkar; Willem A Nolen; Markus M Nöthen; John I Nurnberger; Evaristus A Nwulia; Dale R Nyholt; Colm O'Dushlaine; Robert D Oades; Ann Olincy; Guiomar Oliveira; Line Olsen; Roel A Ophoff; Urban Osby; Michael J Owen; Aarno Palotie; Jeremy R Parr; Andrew D Paterson; Carlos N Pato; Michele T Pato; Brenda W Penninx; Michele L Pergadia; Margaret A Pericak-Vance; Benjamin S Pickard; Jonathan Pimm; Joseph Piven; Danielle Posthuma; James B Potash; Fritz Poustka; Peter Propping; Vinay Puri; Digby J Quested; Emma M Quinn; Josep Antoni Ramos-Quiroga; Henrik B Rasmussen; Soumya Raychaudhuri; Karola Rehnström; Andreas Reif; Marta Ribasés; John P Rice; Marcella Rietschel; Kathryn Roeder; Herbert Roeyers; Lizzy Rossin; Aribert Rothenberger; Guy Rouleau; Douglas Ruderfer; Dan Rujescu; Alan R Sanders; Stephan J Sanders; Susan L Santangelo; Joseph A Sergeant; Russell Schachar; Martin Schalling; Alan F Schatzberg; William A Scheftner; Gerard D Schellenberg; Stephen W Scherer; Nicholas J Schork; Thomas G Schulze; Johannes Schumacher; Markus Schwarz; Edward Scolnick; Laura J Scott; Jianxin Shi; Paul D Shilling; Stanley I Shyn; Jeremy M Silverman; Susan L Slager; Susan L Smalley; Johannes H Smit; Erin N Smith; Edmund J S Sonuga-Barke; David St Clair; Matthew State; Michael Steffens; Hans-Christoph Steinhausen; John S Strauss; Jana Strohmaier; T Scott Stroup; James S Sutcliffe; Peter Szatmari; Szabocls Szelinger; Srinivasa Thirumalai; Robert C Thompson; Alexandre A Todorov; Federica Tozzi; Jens Treutlein; Manfred Uhr; Edwin J C G van den Oord; Gerard Van Grootheest; Jim Van Os; Astrid M Vicente; Veronica J Vieland; John B Vincent; Peter M Visscher; Christopher A Walsh; Thomas H Wassink; Stanley J Watson; Myrna M Weissman; Thomas Werge; Thomas F Wienker; Ellen M Wijsman; Gonneke Willemsen; Nigel Williams; A Jeremy Willsey; Stephanie H Witt; Wei Xu; Allan H Young; Timothy W Yu; Stanley Zammit; Peter P Zandi; Peng Zhang; Frans G Zitman; Sebastian Zöllner; Bernie Devlin; John R Kelsoe; Pamela Sklar; Mark J Daly; Michael C O'Donovan; Nicholas Craddock; Patrick F Sullivan; Jordan W Smoller; Kenneth S Kendler; Naomi R Wray
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  11 in total

1.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Authors:  Michael J Owen; Michael C O'Donovan
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

2.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

3.  The schizophrenia and bipolar twin study in Sweden (STAR).

Authors:  Viktoria Johansson; Christina M Hultman; Isabelle Kizling; Lennart Martinsson; Jacqueline Borg; Anna Hedman; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2018-08-16       Impact factor: 4.939

4.  Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia.

Authors:  Sonja M C de Zwarte; Rachel M Brouwer; Andromachi Tsouli; Wiepke Cahn; Manon H J Hillegers; Hilleke E Hulshoff Pol; René S Kahn; Neeltje E M van Haren
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

5.  Familial aggregation of myocardial infarction and coaggregation of myocardial infarction and autoimmune disease: a nationwide population-based cross-sectional study in Taiwan.

Authors:  Chun-Li Wang; Chang-Fu Kuo; Yung-Hsin Yeh; Mei-Yun Hsieh; Chi-Tai Kuo; Shang-Hung Chang
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

Review 6.  Neurofilaments as Emerging Biomarkers of Neuroaxonal Damage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review.

Authors:  Vincent Davy; Julien Dumurgier; Aurore Fayosse; Claire Paquet; Emmanuel Cognat
Journal:  Diagnostics (Basel)       Date:  2021-04-22

7.  Rationale, Methods, Feasibility, and Preliminary Outcomes of a Transdiagnostic Prevention Program for At-Risk College Students.

Authors:  Anne S Burke; Benjamin G Shapero; Andrea Pelletier-Baldelli; Wisteria Y Deng; Maren B Nyer; Logan Leathem; Leah Namey; Carrie Landa; Corinne Cather; Daphne J Holt
Journal:  Front Psychiatry       Date:  2020-02-25       Impact factor: 4.157

8.  Brain features of nearly drug-naïve female monozygotic twins with first-episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study.

Authors:  Tao Zhang; Jie Song; Ce Chen; Ran Li; Yachen Li; Yun Sun; Tao Fang; Weiwei Xu; Hongjun Tian; Chuanjun Zhuo
Journal:  Brain Behav       Date:  2020-12-08       Impact factor: 3.405

9.  Whole exome sequencing in ADHD trios from single and multi-incident families implicates new candidate genes and highlights polygenic transmission.

Authors:  Bashayer R Al-Mubarak; Aisha Omar; Batoul Baz; Basma Al-Abdulaziz; Amna I Magrashi; Eman Al-Yemni; Amjad Jabaan; Dorota Monies; Mohamed Abouelhoda; Dejene Abebe; Mohammad Ghaziuddin; Nada A Al-Tassan
Journal:  Eur J Hum Genet       Date:  2020-04-01       Impact factor: 5.351

10.  Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

Authors:  Diego Quattrone; Marta Di Forti; Charlotte Gayer-Anderson; Laura Ferraro; Hannah E Jongsma; Giada Tripoli; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Andrei Szöke; Celso Arango; Antonio Lasalvia; Andrea Tortelli; Pierre-Michel Llorca; Lieuwe de Haan; Eva Velthorst; Julio Bobes; Miguel Bernardo; Julio Sanjuán; Jose Luis Santos; Manuel Arrojo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Jean-Paul Selten; Peter B Jones; James B Kirkbride; Alexander L Richards; Michael C O'Donovan; Pak C Sham; Evangelos Vassos; Bart Pf Rutten; Jim van Os; Craig Morgan; Cathryn M Lewis; Robin M Murray; Ulrich Reininghaus
Journal:  Psychol Med       Date:  2018-10-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.